Skip to content

MAZE MAZE Cash ratio

Cash ratio at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
1.4×+0.2×
Septerna, Inc. logo
Septerna, Inc.SEPN
0.9×-18.8×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
3.8×-2.3×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
1.1×-0.8×
Zymeworks logo
ZymeworksZYME
6.9×+5.7×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
0.8×-0.1×

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Calculated from MAZE’s reported figures.

Based on the most recent quarter.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's cash ratio?
MAZE (MAZE) reported cash ratio of 9.4× in Q1 2026.
How has MAZE's cash ratio changed year-over-year?
MAZE's cash ratio decreased by 40.8% year-over-year, from 15.8× to 9.4×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.